ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
801 | 50.44998 | 1 | female | 1 | 6 | 6 | Coma | Coma | 2 | null | null | 55 | 28,491 | null | null | 24 | white | 26.199219 | 50 | 0.520996 | 0.450989 | 1 | 1 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 3 | 63 | 28 | 160 | 30 | 40.89844 | 336.625 | null | 0.899902 | 0.799927 | 140 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.632813 |
802 | 72 | 1 | female | 0 | 13 | 612 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 40,390 | 21,526 | null | 12.5 | black | 15.5 | 15 | 0.885986 | 0.809937 | 1 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 13 | 83 | 8.898438 | 100 | 24 | 37 | 404.75 | null | 0.599976 | 0.899902 | 138 | 7.459961 | null | null | null | null | null | null | 2.584961 |
803 | 65.92999 | 0 | female | 0 | 16 | 1,336 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 60,355 | 30,505.6719 | null | 12.333328 | white | 21 | 29 | 0.809937 | 0.692993 | 1 | 1 | 0 | yes | 0.99 | 0.98 | no dnr | 16 | 63 | 7.099609 | 50 | 20 | 36.5 | null | null | null | 2.099609 | 140 | null | null | null | null | 2 | null | null | 1.839 |
804 | 69.77997 | 0 | male | 0 | 21 | 1,333 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | $25-$50k | 0 | 117,036 | 59,274 | null | 22 | white | 22 | 27 | 0.822998 | 0.711914 | 1 | 0 | 0 | no | null | null | no dnr | 21 | 57 | 8.699219 | 50 | 24 | 37 | 486.625 | 3.199707 | null | 1.299805 | 133 | 7.489258 | null | null | null | null | null | no(M2 and SIP pres) | 2.812988 |
805 | 59.211 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 3 | 14 | >$50k | 41 | 8,126 | 3,478.2188 | null | 20 | white | 18.898438 | 21 | 0.504883 | 0.18399 | 1 | 0 | 0 | metastatic | 0.01 | 0.000001 | dnr after sadm | 1 | 60 | 1.299805 | 90 | 20 | 37.19531 | null | null | null | 1.199951 | 127 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 |
806 | 32.27698 | 1 | female | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 0 | 175,267 | 79,371.5625 | null | 23.5 | white | 29.398438 | 35 | 0.517944 | 0.401978 | 19 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 5 | 117 | 11.5 | 120 | 40 | 36 | 171.40625 | 2.399902 | 1.5 | 1.199951 | 134 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.416504 |
807 | 47.63898 | 1 | female | 0 | 9 | 723 | Lung Cancer | Cancer | 1 | 13 | under $11k | 0 | 13,877 | 7,902.1992 | null | 8 | white | 14.699219 | 16 | 0.785889 | 0.549927 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 9 | 77 | 1.199951 | 80 | 20 | 36.59375 | null | null | null | 0.799927 | 136 | null | null | null | null | 0 | null | null | 0.4948 |
808 | 74.26398 | 1 | male | 0 | 10 | 41 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | >$50k | 0 | 35,636 | 17,422.5 | null | 18 | white | 31.5 | 37 | 0.628906 | 0.445984 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 40 | 6.799805 | 65 | 20 | 36.44531 | null | null | null | 1.5 | 131 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
809 | 71.29895 | 1 | male | 1 | 6 | 6 | Coma | Coma | 0 | 14 | null | 94 | 37,330 | 22,028.1719 | null | 29 | white | 21 | 23 | 0.257996 | 0.190979 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 62 | 21.699219 | 115 | 10 | 38.89844 | 317.125 | null | 0.5 | 1.099854 | 132 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 2.59082 |
810 | 78.05096 | 0 | male | 0 | 26 | 1,328 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 26 | 167,412 | 81,337.0625 | null | 28 | white | 29.5 | 44 | 0.347961 | 0.230988 | 10 | 0 | 0 | yes | null | null | no dnr | 26 | 52 | 8.398438 | 110 | 10 | 38.5 | 98.75 | null | null | 1.399902 | 141 | 7.529297 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
811 | 82.88599 | 0 | male | 0 | 3 | 1,326 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $11-$25k | 0 | 8,568 | 4,712.4023 | null | 8 | white | 15.5 | 17 | 0.822998 | 0.711914 | 1 | 0 | 0 | yes | 0.65 | 0.5 | no dnr | 3 | 85 | 10.099609 | 65 | 16 | 36.5 | null | null | null | 1.099854 | 139 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
812 | 55.37 | 0 | male | 0 | 7 | 1,326 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 30,070 | 16,821.3906 | null | 13.5 | white | 22 | 31 | 0.86792 | 0.780884 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 80 | 6.799805 | 100 | 28 | 35.69531 | null | 4 | 4.099609 | 1.299805 | 132 | null | null | null | null | 1 | 4 | no(M2 and SIP pres) | 4 |
813 | 63.53198 | 0 | male | 0 | 19 | 1,323 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 188,077 | 97,198.875 | null | 16 | other | 20.796875 | 34 | 0.719971 | 0.633911 | 20 | 1 | 0 | no | null | null | no dnr | 19 | 138 | 6.799805 | 100 | 28 | 36.39844 | 254.28125 | null | null | 0.599976 | 136 | 7.489258 | null | null | null | null | null | null | 2.53125 |
814 | 72.32599 | 1 | male | 0 | 8 | 71 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 19 | $25-$50k | 9 | 21,341 | 13,080.7344 | null | 7 | white | 22.699219 | 43 | 0.61792 | 0.431946 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 8 | 71 | 4.599609 | 86 | 16 | 36.39844 | 423.75 | 3.299805 | 4 | 2.099609 | 133 | 7.489258 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.848633 |
815 | 50.64499 | 1 | male | 0 | 4 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 27,047 | 14,579.1094 | null | 10 | white | 19.597656 | 15 | 0.803955 | 0.68396 | 7 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 4 | 77 | 10.898438 | 72 | 22 | 36.19531 | null | null | null | 1.299805 | 130 | null | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
816 | 44.37 | 1 | female | 1 | 8 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 55 | 88,231 | 43,843.0312 | null | 35 | white | 39.695313 | 69 | 0.202972 | 0.061996 | 1 | 0 | 0 | no | null | null | dnr after sadm | 8 | 102 | 38 | 70 | 32 | 36.39844 | 243 | 2.899902 | 42 | 6.799805 | 147 | 7.229492 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
817 | 52.75598 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 100 | 25,511 | 14,848.5469 | null | 25 | white | 48.898438 | 73 | 0.004999 | 0.001 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 3 | 38 | 15.398438 | 0 | 0 | 38.19531 | 186 | null | null | 0.799927 | 156 | 7.069336 | null | null | null | null | null | <2 mo. follow-up | 3.945313 |
818 | 63.27197 | 1 | male | 0 | 8 | 60 | Lung Cancer | Cancer | 1 | null | under $11k | 0 | 11,532 | 6,581.8242 | null | 7.5 | white | 17.597656 | 15 | 0.699951 | 0.412964 | 1 | 0 | 0 | metastatic | 0.8 | 0.512 | dnr after sadm | 4 | 101 | 8.199219 | 78 | 20 | 36 | null | null | null | 0.899902 | 131 | null | null | null | null | 1 | 5 | null | 5 |
819 | 68.20294 | 1 | female | 0 | 44 | 267 | Colon Cancer | Cancer | 2 | 14 | under $11k | 0 | 133,944 | 62,226.3438 | null | 22 | white | 21 | 21 | 0.747925 | 0.487 | 1 | 1 | 0 | metastatic | 0.95 | 0.8 | no dnr | 44 | 113 | 15.599609 | 108 | 28 | 37.19531 | null | null | 1.299805 | 0.799927 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
820 | 72.12598 | 0 | male | 0 | 8 | 1,318 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 41 | 127,395 | null | null | 25 | white | 25.796875 | 45 | 0.520996 | 0.404968 | 7 | 0 | 0 | no | null | null | no dnr | 8 | 113 | 13.298828 | 140 | 37 | 38 | 181.625 | null | null | 1 | 147 | 7.479492 | null | null | null | null | null | null | 4.060547 |
821 | 71.11298 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 2 | 11 | under $11k | 41 | 9,606 | 4,738.4609 | null | 15 | black | 43.796875 | 65 | 0.003 | 0 | 1 | 1 | 0 | metastatic | 0.25 | 0.15 | dnr after sadm | 2 | 33 | 21.097656 | 124 | 32 | 36.79688 | 403.3125 | null | null | 2.099609 | 144 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 3.733887 |
822 | 63.836 | 0 | female | 0 | 9 | 1,315 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | >$50k | 0 | 31,055 | 15,986.5625 | null | 15.5 | white | 22.796875 | 24 | 0.833984 | 0.728882 | 1 | 0 | 0 | no | 0.8 | 0.65 | no dnr | 9 | 70 | 14.798828 | 60 | 20 | 35.69531 | 186.65625 | null | null | 1.399902 | 136 | 7.299805 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
823 | 52.38599 | 0 | male | 0 | 12 | 1,315 | MOSF w/Malig | ARF/MOSF | 1 | 14 | null | 0 | 140,565 | 64,369.125 | null | 26.5 | white | 36.296875 | 42 | 0.283997 | 0.174988 | 15 | 0 | 0 | yes | null | null | no dnr | 12 | 65 | 1 | 100 | 26 | 39.19531 | 122.4375 | null | 3.699707 | 0.799927 | 133 | 7.5 | null | null | null | null | null | no(M2 and SIP pres) | 2.367676 |
824 | 86.04199 | 1 | male | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 37 | 205,980 | 99,348.6875 | null | 36 | white | 26.796875 | 50 | 0.432983 | 0.312988 | 5 | 0 | 0 | no | null | null | dnr after sadm | 12 | 115 | 0.599976 | 110 | 12 | 36.89844 | 231.40625 | null | null | 1.199951 | 144 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
825 | 80.646 | 1 | female | 0 | 16 | 262 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | under $11k | 0 | 34,235 | 21,265.7344 | null | 15 | white | 16.398438 | 22 | 0.85498 | 0.760986 | 1 | 1 | 0 | no | null | null | no dnr | 16 | 80 | 7.5 | 60 | 22 | 36.39844 | 328.5625 | null | null | 1.299805 | 142 | 7.489258 | null | null | null | null | null | no(M2 and SIP pres) | 3.243652 |
826 | 70.034 | 1 | male | 0 | 3 | 208 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 6,528 | 4,963.5117 | null | 8 | white | 21.296875 | 39 | 0.830933 | 0.724976 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 65 | 8.898438 | 85 | 18 | 35.89844 | null | null | null | 2.599609 | 136 | null | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
827 | 65.99896 | 0 | female | 0 | 27 | 1,306 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 11 | null | 0 | 53,190 | 27,477.9375 | null | 14 | white | 18.796875 | 28 | 0.775879 | 0.641968 | 1 | 0 | 0 | no | 0.5 | 0.1 | no dnr | 27 | 75 | 6.899414 | 96 | 24 | 38.19531 | null | 2.299805 | 2.699707 | 0.699951 | 131 | null | null | null | null | 5 | 5 | SIP>=30 | 5 |
828 | 70.59296 | 1 | male | 0 | 6 | 135 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 17,079 | 11,626.0938 | null | 8 | asian | 34.296875 | 45 | 0.22699 | 0.024998 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 6 | 78 | 0.5 | 100 | 16 | 36.79688 | null | 2.5 | 5.199219 | 0.699951 | 132 | null | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
829 | 49.99597 | 1 | female | 1 | 87 | 87 | Coma | Coma | 0 | 14 | under $11k | 44 | 712,554 | null | null | 36 | white | 38.296875 | 60 | 0.125 | 0.078995 | 21 | 0 | 0 | no | null | null | dnr after sadm | 86 | 48 | 17.296875 | 140 | 44 | 39.79688 | 220 | null | 4.5 | 1.399902 | 151 | 7.429688 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
830 | 62.89899 | 0 | female | 0 | 6 | 1,305 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 12,826 | 8,660.6875 | null | 12 | black | 19.699219 | 26 | 0.870972 | 0.785889 | 1 | 1 | 0 | no | null | null | no dnr | 6 | 75 | 5.699219 | 90 | 20 | 37 | 304.75 | null | null | 1.199951 | 126 | 7.439453 | null | null | null | null | null | no(M2 and SIP pres) | 2.188477 |
831 | 55.87698 | 1 | female | 0 | 14 | 66 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 26 | 55,987 | 93.8955 | null | 15.666664 | white | 19.898438 | 31 | 0.822998 | 0.712891 | 1 | 1 | 0 | yes | null | null | dnr after sadm | 2 | 63 | 11.798828 | 95 | 10 | 37.69531 | 187.5 | 3.699707 | 0.5 | 2 | 137 | 7.299805 | null | null | null | null | null | null | 3.985352 |
832 | 42.237 | 1 | female | 0 | 9 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 41,885 | 22,365.5781 | null | 16 | white | 26.796875 | 29 | 0.805908 | 0.740967 | 6 | 0 | 0 | no | 0.15 | 0.05 | no dnr | 9 | 100 | 7.299805 | 82 | 24 | 35.19531 | 136.71875 | null | 5.199219 | 1.199951 | 137 | 7.439453 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
833 | 49.60999 | 0 | female | 0 | 4 | 1,084 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | >$50k | 0 | 5,215 | 3,137.3457 | 3,357.18945 | 8 | white | 15.199219 | 34 | 0.889893 | 0.815918 | 1 | 0 | 0 | no | 0.9 | 0.74 | no dnr | 4 | 71 | 4.899414 | 64 | 22 | 36.39844 | null | 2.299805 | 1.5 | 1.099854 | 139 | null | 104 | 19 | 360 | 1 | 1 | no(M2 and SIP pres) | 1 |
834 | 78.43695 | 1 | female | 0 | 14 | 86 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 9 | 34,499 | 18,041.7344 | 13,913.4531 | 14.333328 | white | 23.898438 | 27 | 0.695923 | 0.531982 | 1 | 0 | 0 | no | 0.4 | 0.2 | dnr after sadm | 2 | 63 | 14.798828 | 72 | 24 | 37.59375 | 157.125 | 3 | 0.399963 | 1.799805 | 140 | 7.339844 | 74 | 35 | 2,600 | null | 3 | adl>=4 (>=5 if sur) | 3 |
835 | 55.98599 | 1 | male | 1 | 27 | 27 | CHF | COPD/CHF/Cirrhosis | 3 | 18 | >$50k | 0 | 90,756 | 45,550.0625 | 57,981.3125 | 21.25 | white | 22.296875 | 25 | 0.862915 | 0.772949 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 27 | 80 | 8.5 | 74 | 20 | 35.59375 | 409.5 | 3.599609 | 1.699951 | 1.599854 | 128 | 7.5 | 141 | 31 | 1,875 | 0 | 0 | <2 mo. follow-up | 0 |
836 | 74.46698 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 41 | 161,673 | 46,653.2188 | 57,038 | 37.666657 | white | 22 | 22 | 0.514893 | 0.397949 | 10 | 0 | 0 | yes | 0.75 | 0.75 | dnr after sadm | 15 | 118 | 9.599609 | 110 | 24 | 39.19531 | 280.9375 | 3.299805 | 0.299988 | 0.599976 | 130 | 7.549805 | 116 | 3 | 3,690 | null | 0 | <2 mo. follow-up | 0 |
837 | 44.90097 | 1 | female | 1 | 25 | 25 | MOSF w/Malig | ARF/MOSF | 4 | 14 | >$50k | 0 | 307,552 | 119,536.188 | 134,474.75 | 36.25 | other | 33.5 | 65 | 0.287964 | 0.177979 | 18 | 1 | 0 | metastatic | 0.75 | 0.5 | dnr after sadm | 23 | 62 | 16.898438 | 95 | 26 | 36.29688 | 125 | 3.399902 | 2.5 | 2.899902 | 144 | 7.479492 | 433 | 40 | 1,240 | null | 0 | <2 mo. follow-up | 0 |
838 | 44.383 | 1 | male | 0 | 29 | 109 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 20 | >$50k | 0 | 246,214 | 61,128.875 | 66,810.9375 | 30.5 | white | 21.296875 | 33 | 0.848999 | 0.797974 | 20 | 1 | 0 | no | 0.2 | 0.1 | no dnr | 29 | 65 | 7.099609 | 80 | 26 | 36.5 | 300 | null | 0.799927 | 2.699707 | 145 | 7.489258 | 139 | 29 | 5,040 | null | null | null | 2.456055 |
839 | 26.51299 | 0 | female | 0 | 13 | 1,079 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 17 | under $11k | 26 | 87,124 | 28,491.8594 | 88,260.25 | 29.5 | hispanic | 34.695313 | 47 | 0.643921 | 0.542969 | 6 | 0 | 0 | no | null | null | no dnr | 13 | 113 | 19 | 135 | 44 | 38.39844 | 95.375 | null | 2.5 | 0.699951 | 133 | 7.5 | 114 | 7 | 6,500 | null | 0 | no(M2 and SIP pres) | 0 |
840 | 70.90796 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 9 | 390,845 | 51,077.6875 | 54,144.125 | 36.666657 | white | 37.695313 | 71 | 0.29895 | 0.187988 | 32 | 0 | 0 | no | 0.01 | 0.01 | dnr after sadm | 1 | 50 | 26.199219 | 120 | 28 | 38.69531 | 392.5625 | null | 5.5 | 2.199707 | 133 | 7.509766 | 213 | 65 | 5,880 | null | null | <2 mo. follow-up | 3.464356 |
841 | 63.64697 | 1 | male | 0 | 23 | 157 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | null | 0 | 142,625 | 60,269.375 | 205,850.25 | 42.333313 | white | 16.796875 | 37 | 0.861938 | 0.814941 | 1 | 0 | 0 | yes | 0.75 | 0.6 | no dnr | 23 | 65 | 7.099609 | 55 | 21 | 37.69531 | 237.125 | 2.199707 | 2.299805 | 0.799927 | 137 | 7.459961 | 215 | 12 | 5,605 | null | 6 | adl>=4 (>=5 if sur) | 6 |
842 | 72.54797 | 1 | female | 0 | 5 | 354 | Colon Cancer | Cancer | 0 | null | null | 0 | 10,862 | 5,092.5898 | 7,937.4375 | 19 | asian | 15.798828 | 12 | 0.819946 | 0.611938 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 5 | 69 | 5.199219 | 72 | 20 | 36.39844 | null | 3.299805 | 0.199982 | 1.099854 | 138 | null | null | 13 | 2,125 | null | null | null | 1.832031 |
843 | 81.24298 | 0 | male | 0 | 26 | 1,076 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | null | 44 | 172,335 | 78,254 | 88,530.5 | 35.75 | white | 31 | 42 | 0.377991 | 0.259949 | 1 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 26 | 60 | 14.5 | 110 | 12 | 38.69531 | 92 | 2.5 | 1.399902 | 1.399902 | 130 | 7.5 | 106 | 23 | 5,075 | null | 2 | no(M2 and SIP pres) | 2 |
844 | 34.59299 | 1 | male | 1 | 13 | 13 | MOSF w/Malig | ARF/MOSF | 2 | 17 | under $11k | 0 | 118,073 | 45,941.9375 | 119,265.875 | 38 | white | 29.199219 | 33 | 0.527954 | 0.412964 | 2 | 0 | 0 | metastatic | 0.6 | 0.3 | dnr after sadm | 7 | 97 | 21.5 | 146 | 32 | 39 | 280.9375 | null | null | 0.599976 | 127 | 7.5 | 119 | 6 | 2,159 | null | 7 | <2 mo. follow-up | 7 |
845 | 61.39398 | 1 | male | 0 | 11 | 20 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $11-$25k | 0 | 54,893 | 23,850.4531 | 28,051.6875 | 31.5 | white | 23.5 | 25 | 0.832886 | 0.726929 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 11 | 75 | 9.798828 | 65 | 20 | 36 | null | null | 1.599854 | 1.799805 | 129 | null | 80 | 63 | 2,375 | null | 2 | <2 mo. follow-up | 2 |
846 | 76.05499 | 0 | male | 0 | 4 | 1,070 | CHF | COPD/CHF/Cirrhosis | 5 | 14 | null | 0 | 7,626 | 4,572.4883 | 4,176.71875 | 9 | white | 20 | 25 | 0.784912 | 0.654907 | 1 | 0 | 1 | yes | 0.6 | 0.5 | no dnr | 4 | 101 | 6.799805 | 114 | 20 | 36.79688 | null | null | 0.599976 | 1.699951 | 139 | null | 161 | 39 | 2,390 | 6 | null | no(M2 and SIP pres) | 4.527344 |
847 | 49.49197 | 0 | female | 0 | 26 | 1,067 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 177,889 | 56,882.1562 | 159,476.75 | 30 | white | 31.5 | 43 | 0.689941 | 0.5979 | 7 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 26 | 105 | 13 | 110 | 30 | 39.29688 | 105 | 4.5 | null | 0.599976 | 147 | 7.469727 | 105 | 25 | 1,480 | null | 7 | no(M2 and SIP pres) | 7 |
848 | 78.03699 | 1 | male | 0 | 15 | 74 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 35,566 | 19,382.1406 | 14,667.875 | 20.666656 | white | 24.699219 | 41 | 0.689941 | 0.523926 | 1 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 1 | 75 | 36.09375 | 70 | 22 | 36 | 414.25 | null | null | 2.5 | 135 | 7.489258 | 90 | 71 | 650 | 5 | null | null | 3.854981 |
849 | 54.02298 | 1 | female | 1 | 46 | 46 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | null | 89 | 676,210 | 179,056.875 | 200,250.125 | 40.5 | white | 36.296875 | 77 | 0.084991 | 0.032997 | 39 | 0 | 0 | no | null | null | no dnr | 46 | 55 | 12.898438 | 115 | 46 | 39.19531 | 290 | 3.299805 | 4.599609 | 3.799805 | 143 | 7.439453 | 74 | 95 | 160 | null | 0 | <2 mo. follow-up | 0 |
850 | 85.10297 | 0 | female | 0 | 14 | 1,065 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 9 | 62,841 | 21,997.9062 | 25,121.2969 | 14.333328 | white | 29.796875 | 34 | 0.495972 | 0.377991 | 5 | 1 | 0 | no | 0.9 | 0.8 | dnr before sadm | -4 | 73 | 10.099609 | 105 | 24 | 38 | 83.32812 | null | null | 1.199951 | 128 | 7.469727 | 353 | 20 | 2,978 | 1 | 1 | no(M2 and SIP pres) | 1 |
851 | 52.02197 | 0 | male | 0 | 52 | 1,063 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 16 | $11-$25k | 26 | 593,198 | 174,370.625 | 200,240.375 | 31.75 | hispanic | 24.898438 | 42 | 0.684937 | 0.591919 | 33 | 0 | 0 | no | null | null | no dnr | 52 | 108 | 3.799805 | 55 | 32 | 38.39844 | 418.3125 | null | 3.599609 | 1.5 | 145 | 7.419922 | 332 | 81 | 1,760 | null | 7 | no(M2 and SIP pres) | 7 |
852 | 86.62799 | 0 | male | 0 | 20 | 1,061 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 26 | 96,480 | 25,141.3281 | 110,968.812 | 25.333328 | white | 25.296875 | 27 | 0.501953 | 0.383972 | 9 | 0 | 0 | no | null | null | no dnr | 20 | 98 | 28.898438 | 75 | 36 | 36.39844 | 142 | null | null | 1 | 150 | 7.519531 | 357 | 16 | null | null | 0 | null | 0 |
853 | 58.95398 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 298,234 | 39,437.875 | 49,378.625 | 34.5 | white | 32.398438 | 56 | 0.570923 | 0.459961 | 71 | 0 | 0 | no | 0.1 | 0.1 | no dnr | 11 | 135 | 5.599609 | 95 | 10 | 39.09375 | 170 | null | 18.898438 | 1.5 | 153 | 7.439453 | 182 | 76 | 1,880 | null | null | <2 mo. follow-up | 3.206543 |
854 | 57.69699 | 1 | male | 0 | 4 | 320 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 12,827 | 5,347.5469 | 5,639.44922 | 7 | white | 16.097656 | 10 | 0.741943 | 0.47699 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 4 | 112 | 11.699219 | 80 | 16 | 37 | null | 3.299805 | 0.299988 | 1 | 141 | null | 94 | 14 | 6,360 | 0 | null | no(M2 and SIP pres) | 0.494751 |
855 | 59.44397 | 1 | male | 1 | 18 | 18 | Coma | Coma | 1 | 24 | >$50k | 0 | 223,643 | 93,965.8125 | 154,506.25 | 54 | white | 20.5 | 33 | 0.784912 | 0.743896 | 1 | 1 | 0 | no | null | null | dnr after sadm | 17 | 142 | 19.296875 | 115 | 8 | 38.79688 | 317.75 | null | 1.899902 | 1.099854 | 144 | 7.509766 | 393 | 33 | 3,050 | null | 0 | <2 mo. follow-up | 0 |
856 | 37.74698 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | $25-$50k | 89 | 577,381 | 99,014.5 | 111,047.625 | 57 | white | 35.695313 | 83 | 0.18399 | 0.095993 | 28 | 0 | 0 | no | 0 | 0 | dnr after sadm | 13 | 62 | 9.199219 | 145 | 12 | 37.89844 | 280 | 4.899414 | 32.695313 | 2.599609 | 138 | 7.489258 | 129 | 71 | 12 | null | 3 | <2 mo. follow-up | 3 |
857 | 52.99698 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 100 | 174,687 | 14,567.3828 | 17,020.0156 | 47 | white | 43.398438 | 74 | 0.011999 | 0.002 | 8 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 3 | 42 | 6.799805 | 105 | 29 | 35.5 | 307.5 | null | 6.399414 | 8 | 145 | 7.389648 | 658 | 98 | 0 | null | null | <2 mo. follow-up | 3.782715 |
858 | 76.28497 | 0 | male | 0 | 35 | 1,060 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | >$50k | 0 | 141,756 | 64,223.875 | 63,816.7188 | 31 | white | 34.195313 | 58 | 0.459961 | 0.340942 | 1 | 0 | 0 | yes | null | null | no dnr | 35 | 72 | 6.299805 | 180 | 10 | 36.79688 | 64 | 2 | null | 0.799927 | 129 | 7.5 | 165 | 26 | 3,450 | null | 1 | adl>=4 (>=5 if sur) | 1 |
859 | 57.53 | 0 | female | 0 | 53 | 1,059 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $25-$50k | 41 | 261,184 | 121,786.438 | 115,827.938 | 29 | white | 33.5 | 58 | 0.399963 | 0.280945 | 1 | 1 | 0 | yes | 0.5 | 0.7 | no dnr | 53 | 58 | 17.5 | 130 | 12 | 38.5 | 325.6875 | 2.599609 | 0.5 | 4.099609 | 125 | 7.429688 | 841 | 66 | 895 | null | 7 | adl>=4 (>=5 if sur) | 7 |
860 | 70.20398 | 1 | male | 0 | 4 | 245 | Lung Cancer | Cancer | 1 | 10 | $25-$50k | 0 | 10,586 | 3,956.8867 | 4,522.85938 | 13 | white | 13.798828 | 10 | 0.756958 | 0.500977 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 4 | 123 | null | 78 | 18 | 36.79688 | null | null | null | 0.899902 | 137 | null | null | 5 | 5,170 | 0 | 0 | SIP>=30 | 0 |
861 | 66.04498 | 1 | male | 0 | 4 | 385 | Lung Cancer | Cancer | 1 | 13 | >$50k | 0 | 11,532 | 4,416.3945 | 4,909.53906 | 13 | white | 16.398438 | 12 | 0.717896 | 0.439941 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 4 | 79 | 11.5 | 80 | 16 | 36.79688 | null | null | null | 1.399902 | 135 | null | null | 15 | 5,250 | 1 | 0 | no(M2 and SIP pres) | 0 |
862 | 42.69397 | 0 | male | 0 | 11 | 1,058 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 76,504 | 28,285.4219 | 29,885.0625 | 37.5 | white | 28.699219 | 27 | 0.792969 | 0.724976 | 3 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 11 | 103 | 2.399902 | 125 | 26 | 39.29688 | 286.625 | 2.5 | 0.5 | 1 | 130 | 7.449219 | 123 | 12 | 2,000 | null | null | null | 3.315918 |
863 | 44.23297 | 0 | male | 0 | 7 | 1,057 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 78,031 | 17,341.1094 | 19,316.0156 | 15 | hispanic | 25.796875 | 39 | 0.80896 | 0.745972 | 7 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 7 | 72 | 19.199219 | 75 | 36 | 38.89844 | 136.71875 | 2.5 | 3.799805 | 1.299805 | 143 | 7.459961 | 101 | 26 | 4,005 | 0 | 0 | no(M2 and SIP pres) | 0 |
864 | 49.892 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | under $11k | 0 | 36,044 | 13,711.9844 | 16,086.1641 | 14.5 | white | 31.5 | 55 | 0.652954 | 0.553955 | 3 | 0 | 0 | yes | 0 | 0 | no dnr | 7 | 70 | 2.299805 | 125 | 35 | 37.89844 | null | null | null | 2.5 | 140 | null | null | 52 | 1,350 | null | 3 | <2 mo. follow-up | 3 |
865 | 20.523 | 1 | male | 0 | 52 | 66 | MOSF w/Malig | ARF/MOSF | 4 | null | $11-$25k | 0 | 784,726 | 180,566 | 189,590.375 | 34.25 | other | 34.5 | 57 | 0.370972 | 0.252991 | 88 | 1 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 52 | 110 | 0.049995 | 118 | 32 | 36.79688 | 236.65625 | null | 5.5 | 0.799927 | 142 | 7.439453 | 251 | 30 | 3,890 | null | 6 | null | 6 |
866 | 62.5 | 1 | female | 0 | 4 | 229 | Lung Cancer | Cancer | 1 | 9 | under $11k | 0 | 10,163 | 4,479.3477 | 4,604.37891 | 16 | white | 11.898438 | 10 | 0.799927 | 0.574951 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 4 | 113 | 6.5 | 80 | 20 | 36 | null | 3.799805 | null | 0.899902 | 138 | null | 194 | 9 | 5,700 | 5 | null | no(M2 and SIP pres) | 3.854981 |
867 | 37.47598 | 1 | male | 1 | 57 | 57 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | $11-$25k | 0 | 270,127 | 120,381.812 | 127,205.188 | 22.75 | hispanic | 21.699219 | 26 | 0.911987 | 0.850952 | 1 | 0 | 0 | no | null | null | no dnr | 57 | 71 | 14.599609 | 55 | 16 | 37.09375 | null | null | 2.599609 | 1.299805 | 131 | null | 99 | 33 | 4,275 | 1 | 0 | <2 mo. follow-up | 0 |
868 | 59.45499 | 1 | female | 0 | 91 | 205 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | >$50k | 0 | 976,623 | 320,064.75 | 374,988.5 | 33 | white | 29.199219 | 57 | 0.656982 | 0.55896 | 26 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 91 | 73 | 4.799805 | 115 | 30 | 38.59375 | 312.5 | 4.599609 | 1.599854 | 3.699707 | 142 | 7.379883 | null | 75 | 238 | null | 2 | adl>=4 (>=5 if sur) | 2 |
869 | 66.26099 | 1 | female | 0 | 7 | 87 | CHF | COPD/CHF/Cirrhosis | 6 | null | null | 26 | 11,494 | 6,642.3359 | 6,104.63672 | 8.5 | black | 13.398438 | 22 | 0.810913 | 0.69397 | 1 | 1 | 0 | metastatic | 0.85 | 0.5 | no dnr | 7 | 110 | 9.599609 | 109 | 20 | 36 | 442.8125 | 4.599609 | 0.899902 | 1.299805 | 137 | 7.469727 | 251 | 23 | 3,420 | null | null | null | 4.881836 |
870 | 59.03598 | 0 | male | 0 | 9 | 1,055 | CHF | COPD/CHF/Cirrhosis | 2 | 20 | >$50k | 0 | 21,359 | 10,872.9297 | 11,947.6094 | 19.5 | white | 34 | 51 | 0.665894 | 0.491943 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 49 | 7.099609 | 120 | 16 | 36.39844 | null | null | null | 2.899902 | 132 | null | 100 | 43 | 1,770 | 0 | 0 | no(M2 and SIP pres) | 0 |
871 | 60.271 | 1 | male | 1 | 55 | 55 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | $25-$50k | 0 | 460,668 | 190,896.5 | 216,081.625 | 33.25 | white | 20.296875 | 32 | 0.830933 | 0.773926 | 1 | 0 | 0 | yes | 0.9 | 0.6 | dnr after sadm | 37 | 115 | 7.799805 | 120 | 20 | 36.89844 | null | null | null | 1.699951 | 143 | null | 154 | 85 | 2,850 | null | 3 | <2 mo. follow-up | 3 |
872 | 20.99699 | 1 | male | 1 | 3 | 3 | Coma | Coma | 3 | 14 | under $11k | 100 | 278,242 | 24,999.6562 | 20,352.4219 | 45 | asian | 47.796875 | 92 | 0.003 | 0.001 | 40 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 60 | 27.5 | 85 | 24 | 35 | 54 | 2.399902 | 20.597656 | 4.099609 | 150 | 6.939453 | 335 | 75 | 110 | null | null | <2 mo. follow-up | 3.309082 |
873 | 55.655 | 0 | female | 0 | 12 | 1,053 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 26 | 34,920 | 19,289.2969 | 20,270.2656 | 20.5 | white | 24.5 | 43 | 0.762939 | 0.687988 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 12 | 75 | 8.298828 | 116 | 8 | 36.59375 | 419 | 3.699707 | 0.199982 | 2 | 154 | 7.549805 | 111 | 63 | 2,030 | null | 5 | adl>=4 (>=5 if sur) | 5 |
874 | 45.43698 | 0 | female | 0 | 93 | 1,053 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 636,886 | null | null | 40.25 | white | 38.398438 | 75 | 0.50293 | 0.385986 | 1 | 0 | 0 | no | 0.4 | 0.5 | no dnr | 93 | 107 | 0.199982 | 140 | 40 | 37.89844 | 178 | null | 3 | 0.5 | 134 | 7.299805 | null | 23 | 2,050 | null | null | null | 2.833008 |
875 | 49.92499 | 1 | male | 0 | 14 | 935 | Colon Cancer | Cancer | 1 | 17 | >$50k | 0 | 23,578 | 12,864.6016 | 14,080.5859 | 7.333332 | white | 20.097656 | 18 | 0.802979 | 0.579956 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 14 | 70 | 11.099609 | 120 | 20 | 39.59375 | null | null | null | null | 140 | null | null | null | 3,450 | 0 | 0 | no(M2 and SIP pres) | 0 |
876 | 42.11899 | 0 | female | 0 | 23 | 1,050 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | null | 26 | 1,086,011 | 48,990.7812 | 62,284.125 | 29 | hispanic | 30.097656 | 56 | 0.608887 | 0.50293 | 147 | 0 | 0 | no | null | null | no dnr | 23 | 72 | 3.899902 | 115 | 28 | 38.19531 | 311.0625 | null | 1.599854 | 2.899902 | 147 | 7.449219 | 78 | 64 | 151 | null | 0 | no(M2 and SIP pres) | 0 |
877 | 75.08795 | 1 | male | 1 | 4 | 4 | Coma | Coma | 4 | null | null | 100 | 157,000 | 22,982.7031 | 25,227.9062 | 51 | white | 52.09375 | 116 | 0 | 0 | 17 | 1 | 0 | yes | null | null | no dnr | 4 | 32 | 0.049995 | 155 | 26 | 38.5 | 126.25 | null | null | 4.599609 | 153 | 7.239258 | 67 | 112 | 0 | null | null | <2 mo. follow-up | 3.80957 |
878 | 44.32599 | 1 | male | 0 | 15 | 526 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 44,950 | 23,775.2188 | 24,613.2969 | 14.333328 | black | 32.398438 | 40 | 0.772949 | 0.637939 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 15 | 73 | 4.899414 | 95 | 26 | 37.5 | null | 2.099609 | 0.299988 | 2.599609 | 129 | null | 154 | 51 | 2,650 | 0 | 0 | SIP>=30 | 0 |
879 | 75.17896 | 0 | male | 0 | 47 | 1,049 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 15 | null | 26 | 191,750 | 67,892.75 | 66,681.9375 | 28.75 | white | 24.5 | 47 | 0.526978 | 0.411987 | 7 | 1 | 0 | yes | 0.5 | 0.95 | no dnr | 47 | 72 | 8 | 100 | 26 | 37.69531 | 172.5 | null | null | 6.199219 | 142 | 7.449219 | 267 | 78 | 935 | null | 0 | null | 0 |
880 | 51.452 | 1 | female | 0 | 6 | 434 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 10,606 | 5,724.3086 | 6,900.46875 | 17 | white | 15 | 12 | 0.772949 | 0.527954 | 1 | 0 | 0 | metastatic | 1 | 0.9 | no dnr | 6 | 73 | 3.399902 | 80 | 20 | 36.19531 | null | null | 0.099991 | 0.699951 | 138 | null | null | 8 | 6,150 | 0 | 0 | no(M2 and SIP pres) | 0 |
881 | 62.37598 | 1 | male | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 3 | 18 | >$50k | 0 | 139,026 | 47,879.5938 | 53,606.2812 | 29.666656 | black | 41.695313 | 71 | 0.132996 | 0.060997 | 12 | 0 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 11 | 108 | 5.399414 | 70 | 12 | 35.89844 | 153.03125 | 2.299805 | 9.599609 | 5.199219 | 127 | 7.419922 | 186 | 101 | 1,131 | null | 4 | <2 mo. follow-up | 4 |
882 | 54.47498 | 0 | male | 0 | 25 | 1,048 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 94,914 | 44,798.6562 | 55,629.2812 | 15.75 | white | 6.299805 | 6 | 0.87793 | 0.723999 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 25 | 97 | 6 | 76 | 20 | 36.19531 | null | 4.099609 | 0.5 | 1.099854 | 138 | null | 165 | 12 | 7,500 | 0 | 0 | no(M2 and SIP pres) | 0 |
883 | 52.62997 | 1 | male | 0 | 5 | 838 | Colon Cancer | Cancer | 1 | null | null | 0 | 12,265 | 7,544.2812 | 8,521.5625 | 10 | white | 13.099609 | 23 | 0.878906 | 0.726929 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 5 | 101 | 10 | 80 | 22 | 37.79688 | null | 3.799805 | 0.399963 | 1.099854 | 132 | null | 114 | 20 | 1,075 | null | null | no(M2 and SIP pres) | 1.857666 |
884 | 75.77496 | 1 | female | 0 | 6 | 716 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | null | 0 | 10,782 | 6,787.6914 | 6,076.12891 | 15 | white | 17.199219 | 9 | 0.859985 | 0.768921 | 1 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 6 | 108 | 10.699219 | 95 | 22 | 36.39844 | null | null | null | 0.899902 | 137 | null | null | 15 | 3,450 | 0 | null | null | 0.494751 |
885 | 76.961 | 0 | female | 0 | 17 | 1,045 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 88,755 | 37,615.1875 | 40,109.4375 | 32.333313 | hispanic | 28 | 34 | 0.642944 | 0.541992 | 4 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 17 | 78 | 9.099609 | 105 | 12 | 36.5 | 440 | null | null | 2 | 126 | 7.439453 | 159 | 30 | 7,219 | null | 3 | adl>=4 (>=5 if sur) | 3 |
886 | 54.71597 | 0 | female | 0 | 10 | 1,045 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | $25-$50k | 0 | 31,403 | 15,863.2109 | 15,708.2656 | 20 | white | 28.097656 | 53 | 0.782959 | 0.712891 | 1 | 1 | 0 | no | 0.3 | 0.25 | no dnr | 10 | 100 | 26.296875 | 75 | 15 | 38 | 108.32812 | 2.399902 | 1.399902 | 2.199707 | 132 | 7.369141 | 119 | 56 | 970 | 2 | 2 | null | 2 |
887 | 79.70398 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 5 | 16 | $11-$25k | 0 | 56,752 | 24,689.4531 | 31,170.0625 | 33.5 | white | 33.5 | 38 | 0.428955 | 0.309998 | 1 | 1 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 9 | 60 | 22 | 110 | 36 | 36.09375 | 108 | 2.599609 | null | 0.5 | 135 | 7.459961 | null | 16 | 1,870 | null | null | <2 mo. follow-up | 3.677246 |
888 | 53.36099 | 1 | male | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 18 | under $11k | 0 | 314,092 | 84,356.8125 | 90,715.5625 | 36 | white | 28.796875 | 40 | 0.724976 | 0.639893 | 7 | 0 | 0 | no | null | null | dnr after sadm | 22 | 97 | 11.599609 | 70 | 32 | 36.79688 | 313.3125 | 3.099609 | 7.799805 | 2.699707 | 140 | 7.419922 | 286 | 96 | 7,660 | null | 0 | <2 mo. follow-up | 0 |
889 | 73.94897 | 1 | male | 0 | 28 | 57 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 44 | 208,988 | 79,771.75 | 95,195.1875 | 45.25 | asian | 31.199219 | 54 | 0.334961 | 0.218994 | 1 | 1 | 0 | yes | 0.15 | 0.05 | dnr after sadm | 8 | 62 | 6.199219 | 115 | 30 | 38 | 127.5 | null | 0.399963 | 2.699707 | 135 | 7.509766 | 160 | 64 | 5,055 | null | null | <2 mo. follow-up | 3.924316 |
890 | 21.20999 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | under $11k | 37 | 73,268 | 28,876.6094 | 37,257.7812 | 27.5 | hispanic | 27.097656 | 57 | 0.804932 | 0.73999 | 2 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 8 | 112 | 7.199219 | 120 | 26 | 38.69531 | 291.375 | 1.599854 | 13.798828 | 0.699951 | 140 | 7.459961 | null | 9 | 1,325 | null | 1 | <2 mo. follow-up | 1 |
891 | 86.35199 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 44 | 125,804 | 11,069.0859 | 12,813.4297 | 31 | white | 42.296875 | 70 | 0.028 | 0.007 | 10 | 0 | 0 | no | 0.25 | 0.25 | dnr before sadm | -3 | 45 | 23.5 | 75 | 36 | 36.19531 | 97 | 2.799805 | null | 2 | 131 | 7.379883 | 310 | 60 | 1,262 | null | 0 | <2 mo. follow-up | 0 |
892 | 33.55197 | 1 | male | 0 | 6 | 442 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 26,882 | 12,281.9531 | 13,067.7891 | 24 | black | 23.699219 | 27 | 0.892944 | 0.85498 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 113 | 15.699219 | 125 | 28 | 39.29688 | 348.5625 | null | null | 1 | 133 | 7.429688 | 69 | 6 | 2,060 | null | null | no(M2 and SIP pres) | 3.226563 |
893 | 64.58295 | 1 | male | 0 | 5 | 155 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 5,751 | 3,211.9102 | 23,493.7031 | 5 | white | 13.298828 | 5 | 0.775879 | 0.533936 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 81 | 5.699219 | 84 | 20 | 37.79688 | null | null | null | 0.799927 | 140 | null | 92 | 11 | 2,775 | null | 0 | null | 0 |
894 | 79.54596 | 1 | female | 0 | 5 | 580 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 44 | 30,631 | 13,084.1094 | 17,486.9062 | 42 | white | 24.398438 | 34 | 0.576904 | 0.465942 | 1 | 1 | 0 | no | 0.7 | 0.6 | no dnr | 5 | 60 | 15.398438 | 25 | 32 | 38.29688 | null | 3 | null | 0.699951 | 146 | null | 189 | 11 | 422 | null | null | null | 3.564941 |
895 | 67.71497 | 0 | female | 0 | 7 | 1,036 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 0 | 46,447 | 10,272.25 | 12,649.1328 | 14.5 | white | 23.597656 | 25 | 0.771973 | 0.697998 | 4 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 7 | 72 | 8.798828 | 72 | 22 | 36.5 | 83.32812 | 2.399902 | 0.699951 | 0.899902 | 133 | 7.539062 | 95 | 11 | 2,050 | 2 | null | no(M2 and SIP pres) | 1.838867 |
896 | 48.73599 | 1 | female | 0 | 26 | 314 | Lung Cancer | Cancer | 1 | null | null | 0 | 117,616 | 50,040.3438 | 57,753.0625 | 12 | white | 14.5 | 12 | 0.785889 | 0.550903 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 26 | 73 | 5 | 96 | 24 | 37.5 | null | null | 0.199982 | 0.899902 | 135 | null | 88 | 9 | 4,735 | null | null | null | 3.026856 |
897 | 63.79498 | 1 | female | 0 | 8 | 68 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 11,253 | 7,390.0273 | 8,001.83984 | 9 | white | 11.5 | 13 | 0.803955 | 0.582886 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 8 | 101 | 6.399414 | 120 | 24 | 36.19531 | null | 4.199219 | 0.399963 | 0.899902 | 140 | null | 79 | null | 2,200 | 4 | null | adl>=4 (>=5 if sur) | 3.183106 |
898 | 88.422 | 1 | male | 0 | 17 | 930 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 111,560 | 36,010.375 | 35,541.2812 | 14.666664 | white | 27.199219 | 56 | 0.439941 | 0.320984 | 8 | 0 | 1 | no | null | null | no dnr | 17 | 72 | 17.199219 | 145 | 36 | 38.69531 | 148.3125 | 2.699707 | 0.399963 | 1.099854 | 146 | 7.479492 | 131 | 21 | 1,975 | null | null | null | 6.273438 |
899 | 54.38199 | 1 | male | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 13 | $11-$25k | 44 | 508,881 | 77,303.1875 | 88,043.3125 | 48 | white | 38.398438 | 60 | 0.141998 | 0.066986 | 35 | 0 | 0 | yes | 0.7 | 0.7 | dnr after sadm | 16 | 117 | 5.099609 | 45 | 27 | 38 | 265 | 3.799805 | 29.5 | 4.899414 | 144 | 7.429688 | 140 | 99 | 619 | null | 2 | <2 mo. follow-up | 2 |
900 | 63.62198 | 0 | male | 0 | 9 | 1,027 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | null | 0 | 36,522 | 18,165.5312 | 22,120.875 | 22.5 | white | 31.597656 | 24 | 0.691895 | 0.525879 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 9 | 45 | 12 | 115 | 16 | 36.59375 | null | null | null | 1 | 131 | null | 106 | 16 | 2,960 | 0 | 1 | no(M2 and SIP pres) | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.